Purchases and Sales Made in Q4 2021 in Corvus Pharmaceuticals, Inc. (CRVS)
This table provides information about the institutional ownership of Corvus Pharmaceuticals, Inc. (CRVS) during Q4 2021. The information is specifically focused on institutions that hold shares of Corvus Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 17, 2022
Q4 2021
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-19.7KClosed |
$46.1K - $105K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Two Sigma Securities, LLC
New York, NY |
SELL
|
- |
-22.8KClosed |
$53.3K - $121K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-27.5K- 36.29% |
$64.3K - $146K
|
48.2K
$231K
|
|
|
Feb 14, 2022
Q4 2021
|
Hrt Financial LP
New York, NY |
SELL
|
- |
-30.8KClosed |
$72K - $163K
|
0
$0
|
|
|
Feb 11, 2022
Q4 2021
|
Affinity Asset Advisors, LLC
New York, NY |
SELL
|
- |
-50KClosed |
$117K - $266K
|
0
$0
|
|
|
Feb 11, 2022
Q4 2021
|
Dc Investments Management, LLC
Mclean, VA |
SELL
|
- |
-50.7KClosed |
$119K - $269K
|
0
$0
|
|
|
Feb 11, 2022
Q4 2021
|
Myda Advisors LLC
Inwood, NY |
SELL
|
- |
-60KClosed |
$140K - $319K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-200KClosed |
$468K - $1.06M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Pura Vida Investments, LLC
New York, NY |
SELL
|
- |
-242K- 32.94% |
$566K - $1.28M
|
492K
$2.36M
|
|
|
Feb 14, 2022
Q4 2021
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-275K- 36.29% |
$643K - $1.46M
|
483K
$2.32M
|
|
|
Feb 14, 2022
Q4 2021
|
Tang Capital Management LLC
San Diego, CA |
SELL
|
- |
-648K- 17.27% |
$1.52M - $3.44M
|
3.1M
$14.9M
|
|
|
Feb 14, 2022
Q4 2021
|
Eco R1 Capital, LLC
San Francisco, CA |
SELL
|
- |
-2.08MClosed |
$4.87M - $11.1M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Vr Adviser, LLC
New York, NY |
SELL
|
- |
-3.18M- 92.71% |
$7.44M - $16.9M
|
250K
$1.2M
|